North America Sepsis Diagnostics Market Trends, Size, Segment and Growth by Forecast  (2021-2028)

The North America sepsis diagnostics market is expected to grow from US$ 279.06 million in 2021 to US$ 513.33 million by 2028. It is estimated to record a CAGR of 9.1% from 2021 to 2028.

High Incidence of Sepsis due to Increasing Nosocomial Infections Drives North America Sepsis Diagnostics Market 

The fundamental precursor to sepsis is infection, with a heightened risk profile observed among individuals exhibiting compromised immunity, such as those undergoing chemotherapeutic treatments, individuals who have undergone splenectomy, and those managing conditions like AIDS, diabetes, and a range of other chronic illnesses. Conspicuously, nosocomial infections emerge as a principal contributor to both morbidity and mortality within the context of hospitalized care. The Centers for Disease Control and Prevention's (CDC) "2020 National and State Healthcare-Associated Infections Progress Report" (published in 2021) revealed that the United States experienced increments of approximately 24% in central line-associated bloodstream infections, 35% in ventilator-associated events, and 15% in Methicillin-resistant Staphylococcus
aureus (MRSA) bacteremia between 2019 and 2020. As per a report issued by the Global Sepsis Alliance (GSA), approximately 26 million individuals globally develop sepsis annually, culminating in roughly 8 million deaths. Consequently, the burgeoning incidence of bloodstream infections is anticipated to stimulate
greater adoption of sepsis diagnostic products. Furthermore, mortality frequently originates from diarrheal diseases or lower respiratory infections, a significant proportion of which are amenable to prevention through timely diagnosis and appropriate clinical management. Thus, the substantial incidence rate of sepsis is projected to amplify the demand for sepsis diagnostic products, which would underpin the expansion of the North America sepsis diagnostics industry throughout the projected timeframe.  

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00025664

North America Sepsis Diagnostics Strategic Insights

Strategic insights pertaining to the North America Sepsis Diagnostics sector provide data-informed analyses of the industry's operational sphere, encompassing contemporary trends, major market participants, and specific regional dynamics. These insights furnish pragmatic recommendations, allowing readers to
distinguish their strategies from those of competitors by identifying unexploited market niches or devising innovative value propositions. Through the utilization of data analytics, these insights aid industry participants—be they investors, manufacturers, or other interested parties—in proactively forecasting market transformations. A prospective orientation is of paramount significance, aiding stakeholders in anticipating market fluctuations and strategically positioning their endeavors for enduring success within this evolving regional landscape. Ultimately, efficacious strategic insights empower readers to make judicious decisions that optimize profitability and facilitate the realization of their strategic business goals within the market.

North America Sepsis Diagnostics Market Segmentation

North America Sepsis Diagnostics Market: By Product

·        
Instruments

·        
Reagents and Assays

·        
Blood Culture Media

·        
Software

North America Sepsis Diagnostics Market: By Technology

·        
Molecular Diagnostics

North America Sepsis Diagnostics Market: By Flow

·     (Cytometry, Microfluidics, Immunoassay,
Biomarkers, Microbiology)

North America Sepsis Diagnostics Market: By Method

·        
Automated Diagnostics and Conventional Diagnostics

North America Sepsis Diagnostics Market: By Test Type

·        
Point-of-Care Tests and Laboratory Tests

North America Sepsis Diagnostics Market: Regions and Countries Covered         

North America

·        
US

·        
Canada

·        
Mexico

North America Sepsis Diagnostics Market: Market leaders and key company profiles    

·        
Abbott

·        
BD

·        
bioMerieux SA

·        
Danaher (Beckman Coulter)

·        
F. HOFFMANN-LA ROCHE LTD.

·        
Immunexpress Inc.

·        
Luminex Corporation

·        
T2 Biosystems, Inc.

·        
THERMO FISHER SCIENTIFIC INC.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications